Guggenheim reiterates Alumis stock rating on psoriasis trial data

15 hours ago 1
Read Entire Article
  1. Homepage
  2. Money
  3. Guggenheim reiterates Alumis stock rating on psoriasis trial data

Related

Trump hails ‘progress’ on Iran deal but threatens huge infrastructure attack

Trump hails ‘progress’ on Iran deal but threatens huge infra...

6 minutes ago 0
Primaris REIT Announces AGM and Financial Results Release Date, Webcast, and Conference Call

Primaris REIT Announces AGM and Financial Results Release Da...

7 minutes ago 0
Unilever nears deal to combine food division with spice maker McCormick

Unilever nears deal to combine food division with spice make...

53 minutes ago 1

Trending

1. Joann's closing
2. Texas Tech basketball
3. UNC basketball
4. Monster Hunter Wilds
5. Ketamine
6. Macron
7. UPMC Memorial shooting
8. Eagles
9. Hims stock
10. Joel Embiid

Popular

Knicks bulldozed late in loss to Thunder as Shai Gilgeous-Alexander dominates crunch time

Knicks bulldozed late in loss to Thunder as Shai Gilgeous-Al...

21 hours ago 5
Powerful X-class solar flare triggers radio blackout ahead of Artemis 2 launch

Powerful X-class solar flare triggers radio blackout ahead o...

12 hours ago 4
Sun rises on Artemis 2 launch pad | Space photo of the day for March 30, 2026

Sun rises on Artemis 2 launch pad | Space photo of the day f...

10 hours ago 4
MLB best bets, odds: Mets vs. Cardinals, Rangers vs. Orioles picks, predictions Monday

MLB best bets, odds: Mets vs. Cardinals, Rangers vs. Orioles...

5 hours ago 4
Celine Dion Announces 2026 Paris Residency Dates, Says She’s Feeling ‘Strong’ After Health Battle

Celine Dion Announces 2026 Paris Residency Dates, Says She’s...

4 hours ago 4
English (US) English (US)
About Us · Contact Us · Terms & Conditions ·

© Fresh 2026. All rights are reserved